FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Guide on PTA and Specialty Catheter 510(k)s

FDA releases a draft guidance on Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters Premarket Notification (510(k)) Submi...

Human Drugs

SCA Pharma 6-item Form 483 After Inspection

FDA issues SCA Pharmaceuticals a six-observation Form 483 after a November inspection cited GMP issues at the drug outsourcing facility.

Medical Devices

Bayer Removes from Market 99% of Essure Devices

A year after Bayer stopped selling and distributing its Essure implantable contraceptive device, CDRH director Jeff Shuren says Bayer has repossessed ...

Federal Register

Meeting on Asbestos in Talc and Cosmetic Products

Federal Register notice: FDA announces a 2/4 public meeting entitled Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc.

Biologics

Meissa Gains Fast Track for RSV Infection Vaccine

FDA grants Meissa Vaccines a fast track designation for MV-012-968, a vaccine for protection against respiratory syncytial virus infection.

Medical Devices

Reflow Medical Breakthrough for Stent System

FDA grants Reflow Medical a breakthrough device designation for the Temporary Spur Stent System, a novel retrievable stent technology intended for tre...

Medical Devices

MicroVention Flow Diverter OKd for Brain Aneurysm

FDA approves a MicroVention PMA for the FRED (Flow Re-Direction Endoluminal Device) device for treating brain aneurysms.

Petition Seeks to Stop FDA Enforcement on PGx Info

The Coalition to Preserve Access to Pharmacogenomics Information petitions FDA urging it to stop enforcement actions against genetic tests that claim ...

Human Drugs

Alnylam Rolling NDA for Lumasiran

Alnylam Pharmaceuticals begins a rolling submission of its NDA for lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for trea...

Human Drugs

Companies Recall Ranitidine, Nizatidine

FDA says Appco and Northwind have recalled ranitidine and Mylan has recalled nizatidine due to potential NDMA contamination.